Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration (Q57267021)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Effectiveness of occlusive bedding in the treatment of atopic dermatitis--a placebo-controlled trial of 12 months' duration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

placebo-controlled trial

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L Holm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Bengtsson

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Ohman

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Scheynius

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

152-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

House dust mite control measures in the management of asthma: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Do mite avoidance measures affect mite and cat airborne allergens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Allergen avoidance in the treatment of asthma and atopic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Mite allergens during 18 months of intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with astham

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Skin prick tests and specific IgE in adults from three different areas of Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Sensitization to allergens of house-dust mite in adults with atopic dermatitis in a cold temperate region

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Exposure to an abundance of cat (Fel d 1) and dog (Can f 1) allergens in Swedish farming households

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Mites in House Dust in the Stockholm Area

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Mite allergens in relation to home conditions and sensitization of asthmatic children from three climatic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

House dust mite sensitization in children and residential characteristics in a temperate region

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Sensitization to Domestic Mites in a Cold Temperate Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Pityrosporum species as a cause of allergy and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Peripheral blood T-cell receptor beta-chain V-repertoire in atopic dermatitis patients after in vitro exposure to Pityrosporum orbiculare extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

Patch test reactions to mite antigens: a GERDA multicentre study. Groupe d'Etudes et de Recherches en Dermato-Allergie

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

A new patch test preparation of dust mites for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Evaluation of variables influencing the outcome of the atopy patch test

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Quantitative assessments of IgG and IgE antibodies to inhalant allergens in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Association between atopic sensitization and asthma and bronchial hyperresponsiveness in swedish adults: pets, and not mites, are the most important allergens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

House-dust-mite allergen concentrations (Der f 1) and mold spores in apartment bedrooms before and after installation of insulated windows and central heating systems

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

In vivo relevance of CD30 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Soluble cytokine receptor CD30 in atopic disorders: a case-control study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

School as a risk environment for children allergic to cats and a site for transfer of cat allergen to homes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Staphylococcal Toxins Augment Specific IgE Responses by Atopic Patients Exposed to Allergen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

Positive atopy patch test reactions to Pityrosporum orbiculare in atopic dermatitis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.056002152.X

7 January 2021

10.1034/J.1398-9995.2001.056002152.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11167376%20AND%20SRC:MED&resulttype=core&format=json